UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research

Value in health, 2016-12, Vol.19 (8), p.929-935

2016

Volltextzugriff (PDF)

Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial

BMC medical research methodology, 2010-06, Vol.10 (1), p.54-54, Article 54

2010

Volltextzugriff (PDF)

Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now?

Value in health, 2020-12, Vol.23 (12), p.1613-1621

2020

Volltextzugriff (PDF)

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts

PLoS medicine, 2017-03, Vol.14 (3), p.e1002254-e1002254

2017

Volltextzugriff (PDF)

Classifying information-sharing methods

BMC medical research methodology, 2021-05, Vol.21 (1), p.107-107, Article 107

2021

Volltextzugriff (PDF)

Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee

PloS one, 2017-03, Vol.12 (3), p.e0172749-e0172749

2017

Volltextzugriff (PDF)

Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Health technology assessment (Winchester, England), 2024-06, Vol.28 (28), p.1-238

2024

Volltextzugriff (PDF)

Concomitant health benefits package design and research prioritisation: development of a new approach and an application to Malawi

BMJ global health, 2021-12, Vol.6 (12), p.e007047

2021

Volltextzugriff (PDF)

Antimicrobial drug pricing

Communications medicine, 2024-10, Vol.4 (1), p.198-5, Article 198

2024

Volltextzugriff (PDF)

Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Health technology assessment (Winchester, England), 2024-10, Vol.28 (73), p.1-230

2024

Volltextzugriff (PDF)

Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain

BMC medical research methodology, 2016-10, Vol.16 (1), p.131-131, Article 131

2016

Volltextzugriff (PDF)

Developing a Modeling Framework for Quantifying the Health and Cost Implications of Antibiotic Resistance for Surgical Procedures

MDM policy & practice, 2023-01, Vol.8 (1), p.23814683231152885-23814683231152885

2023

Volltextzugriff (PDF)

No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data

Value in health, 2009-09, Vol.12 (6), p.996-1003

2009

Volltextzugriff (PDF)

Practical metrics for establishing the health benefits of research to support research prioritisation

BMJ global health, 2020-08, Vol.5 (8), p.e002152

2020

Volltextzugriff (PDF)

Prioritizing Pharmacogenetic Research: A Value of Information Analysis of CYP2D6 Testing to Guide Breast Cancer Treatment

Value in health, 2011-12, Vol.14 (8), p.989-1001

2011

Volltextzugriff (PDF)

Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales: A Cost-Utility Analysis

Value in health, 2012-07, Vol.15 (5), p.759-770

2012

Volltextzugriff (PDF)

Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required

Health economics, 2024-04, Vol.33 (4), p.804-819

2024

Volltextzugriff (PDF)

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness

European urology oncology, 2018-12, Vol.1 (6), p.449-458

2018

Volltextzugriff (PDF)

Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems

Health economics, 2021-11, Vol.30 (11), p.2649-2666

2021

Volltextzugriff (PDF)

Acupuncture for chronic pain and depression in primary care: a programme of research

Programme grants for applied research, 2017-01, Vol.5 (3), p.1-316

2017

Volltextzugriff (PDF)

Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop

The Lancet infectious diseases, 2024-01, Vol.24 (1), p.e47-e58

2024

Volltextzugriff (PDF)

6566 When should statins be started in children with familial hypercholesterolaemia? developing evidence from a united kingdom paediatric fh register

Archives of disease in childhood, 2024-08, Vol.109 (Suppl 1), p.A170-A171

2024

Volltextzugriff (PDF)

How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis

Atherosclerosis, 2023-02, Vol.367, p.40-47

2023

Volltextzugriff (PDF)

Assessing the Value of New Treatments for Hepatitis C: Are International Decision Makers Getting this Right?

PharmacoEconomics, 2016-05, Vol.34 (5), p.427-433

2016

Volltextzugriff (PDF)

Response to Comments on “No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data”

Value in health, 2010, Vol.13 (5), p.683-683

2010

Volltextzugriff (PDF)

1 – 25 von 289

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(245)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(289)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research

Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial

Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now?

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts

Classifying information-sharing methods

Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee

Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Concomitant health benefits package design and research prioritisation: development of a new approach and an application to Malawi

Antimicrobial drug pricing

Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain

Developing a Modeling Framework for Quantifying the Health and Cost Implications of Antibiotic Resistance for Surgical Procedures

No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data

Practical metrics for establishing the health benefits of research to support research prioritisation

Prioritizing Pharmacogenetic Research: A Value of Information Analysis of CYP2D6 Testing to Guide Breast Cancer Treatment

Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales: A Cost-Utility Analysis

Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness

Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems

Acupuncture for chronic pain and depression in primary care: a programme of research

Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop

6566 When should statins be started in children with familial hypercholesterolaemia? developing evidence from a united kingdom paediatric fh register

How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis

Assessing the Value of New Treatments for Hepatitis C: Are International Decision Makers Getting this Right?

Response to Comments on “No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data”

Suchergebnisse filtern